GlaxoSmithKline completed its $1.65 billion acquisition of Reliant Pharmaceuticals on Wednesday. The deal boosts GlaxoSmithKline's cardiovascular medicines portfolio with the addition Reliant's ...

If you have been taking fish oil supplements in an effort to smooth out erratic heart beats caused by atrial fibrillation, you can save your money, researchers said Monday. The largest study of ...

Lovaza is the FDA-approved n-3FA formulation containing 465 mg of EPA and 375 mg of DHA per gram. For this study, we utilized stored plasma samples from our subjects obtained at baseline, 1 year ...

British drug maker GlaxoSmithKline agreed to acquire Reliant Pharmaceuticals, a privately held specialty drug company with a focus on heart medicines, for $1.65 billion, the companies announced ...

Lovaza was launched in the U.S. in 2004 under the brand name Omacor by Reliant Pharmaceuticals, a specialty drug company linked to the billionaire Pritzker clan. In 2007, ...

Teva (TEVA) announces the approval of the generic equivalent to Lovaza in the United States. Teva believes it is first-to-file and thus far is the only company to receive an approval from FDA.

GlaxoSmithKline launched new TV spots last week for Lovaza, a prescription omega-3 fish oil capsule indicated for the lowering of very high triglyceride levels. TV spots, as well as the consumer print ...

GlaxoSmithKline launched new TV spots last month for Lovaza, a prescription omega-3 fish oil capsule indicated for the lowering of very high triglyceride levels. TV spots, as well as the consumer ...

Teva believes that it was the first to file and the only company to receive approval for generic Lovaza. Thus, the company may enjoy 180 days of marketing exclusivity. The product will be launched ...

ALL FOR LOVAZA. Share. Share. Tweet. Email. In the year since it was officially introduced in the United States, Lovaza is on target to top $1 billion in sales this year.

New Strength for Nuvigil Launched Teva Pharmaceuticals announced the launch of Omega-3-Acid Ethyl Esters Capsules, USP, a generic version of GlaxoSmithKline's Lovaza. Teva announced the launch of ...